Home - Products - Others - Other Targets - 1-(2-Amino-5-hydroxyphenyl)propan-1-one

1-(2-Amino-5-hydroxyphenyl)propan-1-one

CAS No. 35364-15-9

1-(2-Amino-5-hydroxyphenyl)propan-1-one( —— )

Catalog No. M23109 CAS No. 35364-15-9

1-(2-Amino-5-hydroxyphenyl)propan-1-one is a useful synthetic intermediate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 39 In Stock
25MG 59 In Stock
50MG 78 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-(2-Amino-5-hydroxyphenyl)propan-1-one
  • Note
    Research use only, not for human use.
  • Brief Description
    1-(2-Amino-5-hydroxyphenyl)propan-1-one is a useful synthetic intermediate.
  • Description
    1-(2-Amino-5-hydroxyphenyl)propan-1-one is a useful synthetic intermediate. It is used in the asymmetrical synthesis of (S)-4-ethyl-6,7,8,10- tetrahydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione, a key intermediate for synthesis of irinotecan and other camptothecin analogs. It is also used in the synthesis of E- ring- modified (RS) - camptothecin analogs as antitumor agents.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    35364-15-9
  • Formula Weight
    165.19
  • Molecular Formula
    C?H??NO?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Henegar, K., et al.: J. Org. Chem., 62, 6588 (1997); Ejima, A., et al.: Chem. Pharma. Bull., 40, 683 (1992)
molnova catalog
related products
  • 1-Hydroxy-2,3,4,7-te...

    1-Hydroxy-2,3,4,7-tetramethoxy-xanthone has vasodilatory action, it can cause vasodilation in the coronary artery pre-contracted with 1uM 5-hydroxytryptamine (5-HT), with the EC 50 value of 6.6±1.4 uM.

  • Pomalidomide-C9-COOH

    Pomalidomide-C9-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.

  • Setipiprant

    Setipiprant is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2).